Novavax Inc. (NVAX)’s Covid Vaccine Might Hit U.S. Market Soon But there are Many Concerns
The outbreak of Covid-19 ushered the world into utter chaos, followed by continuous fear. Pharma giants rushed to make a viable vaccine for the virus that was not slowing down despite worldwide mobility restrictions and lockdowns. While developing a vaccine was a challenge in itself, a viable one even more so, and to top it …